Literature DB >> 22047710

piR-823, a novel non-coding small RNA, demonstrates in vitro and in vivo tumor suppressive activity in human gastric cancer cells.

Jia Cheng1, Hongxia Deng, Bingxiu Xiao, Hui Zhou, Fei Zhou, Zhisen Shen, Junming Guo.   

Abstract

Piwi-interacting RNAs (piRNAs), new non-coding small RNAs, are association with chromatin organization, messenger RNA stability and genome structure. However, the roles of piRNA in carcinogenesis are not clearly defined. By using real-time reverse transcription-polymerase chain reaction technology, we found that the expression level of piR-823 in gastric cancer tissues was significant lower than that in non-cancerous tissues. After increase the level of piR-823 in gastric cancer cells, cell growth was inhibited. The results of xenograft nude mice model confirmed its tumor suppressive properties. All of the evidences indicated that piR-823 play a crucial role in the occult of gastric cancer.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22047710     DOI: 10.1016/j.canlet.2011.10.004

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  116 in total

1.  PIWI-interacting RNA 021285 is involved in breast tumorigenesis possibly by remodeling the cancer epigenome.

Authors:  Alan Fu; Daniel I Jacobs; Aaron E Hoffman; Tongzhang Zheng; Yong Zhu
Journal:  Carcinogenesis       Date:  2015-07-25       Impact factor: 4.944

2.  Detection of stably expressed piRNAs in human blood.

Authors:  Xiao Yang; Yidong Cheng; Qiang Lu; Jifu Wei; Haiwei Yang; Min Gu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

3.  piR-55490 inhibits the growth of lung carcinoma by suppressing mTOR signaling.

Authors:  Liping Peng; Lei Song; Chaoying Liu; Xiaohong Lv; Xiaoping Li; Jing Jie; Dan Zhao; Dan Li
Journal:  Tumour Biol       Date:  2015-09-25

4.  PIWIL4 Maintains HIV-1 Latency by Enforcing Epigenetically Suppressive Modifications on the 5' Long Terminal Repeat.

Authors:  Zhangping He; Shuliang Jing; Tao Yang; Jingliang Chen; Feng Huang; Wanying Zhang; Zhilin Peng; Bingfeng Liu; Xiancai Ma; Liyang Wu; Ting Pan; Xu Zhang; Linghua Li; Weiping Cai; Xiaoping Tang; Junsong Zhang; Hui Zhang
Journal:  J Virol       Date:  2020-05-04       Impact factor: 5.103

Review 5.  Computational Methods and Online Resources for Identification of piRNA-Related Molecules.

Authors:  Yajun Liu; Aimin Li; Guo Xie; Guangming Liu; Xinhong Hei
Journal:  Interdiscip Sci       Date:  2021-04-22       Impact factor: 2.233

6.  piRNA-3878 targets P450 (CpCYP307B1) to regulate pyrethroid resistance in Culex pipiens pallens.

Authors:  Wenyun Ye; Xianmiao Liu; Juxin Guo; Xueli Sun; Yan Sun; Bo Shen; Dan Zhou; Changliang Zhu
Journal:  Parasitol Res       Date:  2017-07-11       Impact factor: 2.289

Review 7.  Small non-coding RNA and cancer.

Authors:  Giulia Romano; Dario Veneziano; Mario Acunzo; Carlo M Croce
Journal:  Carcinogenesis       Date:  2017-05-01       Impact factor: 4.944

Review 8.  Non-coding RNAs underlying chemoresistance in gastric cancer.

Authors:  Arash Poursheikhani; Zahra Bahmanpour; Ehsan Razmara; Ladan Mashouri; Mohammad Taheri; Dorsa Morshedi Rad; Hassan Yousefi; Amirreza Bitaraf; Sadegh Babashah
Journal:  Cell Oncol (Dordr)       Date:  2020-06-03       Impact factor: 6.730

9.  Altered expression of piRNAs and their relation with clinicopathologic features of breast cancer.

Authors:  G Huang; H Hu; X Xue; S Shen; E Gao; G Guo; X Shen; X Zhang
Journal:  Clin Transl Oncol       Date:  2012-11-15       Impact factor: 3.405

10.  Genetic variants in the PIWI-piRNA pathway gene DCP1A predict melanoma disease-specific survival.

Authors:  Weikang Zhang; Hongliang Liu; Jieyun Yin; Wenting Wu; Dakai Zhu; Christopher I Amos; Shenying Fang; Jeffrey E Lee; Yi Li; Jiali Han; Qingyi Wei
Journal:  Int J Cancer       Date:  2016-09-14       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.